Compounds > parecoxib
Page last updated: 2024-09-03

parecoxib and cox 189

parecoxib has been researched along with cox 189 in 3 studies

Compound Research Comparison

Studies
(parecoxib)		Trials
(parecoxib)		Recent Studies (post-2010)
(parecoxib)		Studies
(cox 189)		Trials
(cox 189)		Recent Studies (post-2010) (cox 189)
4361862291634947

Protein Interaction Comparison

ProteinTaxonomyparecoxib (IC50)cox 189 (IC50)
Prostaglandin G/H synthase 1Homo sapiens (human)0.007
Prostaglandin G/H synthase 2Homo sapiens (human)0.076
Prostaglandin G/H synthase 2Mus musculus (house mouse)0.04

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frölich, JC; Stichtenoth, DO1
Deray, G; Montalescot, G; Sibilia, J1
Elliott, WJ1

Reviews

3 review(s) available for parecoxib and cox 189

ArticleYear
The second generation of COX-2 inhibitors: what advantages do the newest offer?
    Drugs, 2003, Volume: 63, Issue:1

    Topics: Clinical Trials as Topic; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Drug Interactions; Etoricoxib; Humans; Isoenzymes; Isoxazoles; Membrane Proteins; Organic Chemicals; Prostaglandin-Endoperoxide Synthases; Pyridines; Sulfonamides; Sulfones

2003
[What do we know about the cardiovascular toxicity of the NSAIDs?].
    Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:9 Spec No

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Case-Control Studies; Celecoxib; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Follow-Up Studies; Humans; Isoxazoles; Lactones; Meta-Analysis as Topic; Middle Aged; Naproxen; Pyrazoles; Randomized Controlled Trials as Topic; Risk Factors; Sulfonamides; Sulfones; Thrombosis; Time Factors

2006
Do the blood pressure effects of nonsteroidal antiinflammatory drugs influence cardiovascular morbidity and mortality?
    Current hypertension reports, 2010, Volume: 12, Issue:4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Celecoxib; Cyclooxygenase 2 Inhibitors; Diclofenac; Etoricoxib; Humans; Hypertension; Isoxazoles; Lactones; Pyrazoles; Pyridines; Risk; Risk Factors; Sulfonamides; Sulfones

2010